https://biostempharma.com/
Biostem Pharma – PCD Pharma Franchise India
pcd franchisebiostempharmaindia
https://markets.businessinsider.com/news/stocks/biostem-technologies-reports-record-preliminary-fourth-quarter-net-revenue-of-102-9-million-and-preliminary-full-year-2024-revenue-of-301-8-million-1034581841
BioStem Technologies Reports Record Preliminary Fourth-Quarter Net Revenue of $102.9 Million and...
Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for 2024Achi...
https://biostemtechnologies.com/
Home | BioStem Technologies
Mar 25, 2026 - BioStem Technologies® produces innovative perinatal tissue-based allografts, including VENDAJE®, VENDAJE AC® and VENDAJE® optic.
biostemtechnologies
https://www.nasdaq.com/market-activity/stocks/bsem/option-chain
BioStem Technologies Inc (BSEM) Option Chain | Nasdaq
View the most recent data and latest information on option chains for BioStem Technologies Inc (BSEM) at Nasdaq.com.
option chainbiostemtechnologiesincbsem
https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/biostem-life-sciences-673788-01172025
BioStem Life Sciences - 673788 - 01/17/2025 | FDA
life sciencesbiostemfda
https://rss.globenewswire.com/fr/news-release/2025/01/02/3003454/0/en/BioStem-Technologies-CEO-to-Present-at-Biotech-Showcase-2025.html
BioStem Technologies CEO to Present at Biotech Showcase
BioStem Technologies CEO to Present at Biotech Showcase 2025...
biostemtechnologiesceopresentbiotech
https://www.tnbioteched.org/
Home | The Tennessee Coalition for Health Science & BioSTEM Education
for healthtennesseecoalitionsciencebiostem
https://markets.businessinsider.com/news/stocks/biostem-technologies-reports-fourth-quarter-and-full-year-2025-financial-results-1035959943
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results | Markets Insider
POMPANO BEACH, Fla., March 24, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused ...